Immunological Responses to Plasmodium vivax Malaria

Plasmodium vivax infection presents a unique challenge to the human immune system owing to its ability to form dormant liver stages, invade young red blood cells and trigger relapses weeks or months after the initial attack. Innate responses engage monocytes, dendritic cells and natural killer cells, which limit parasite multiplication and shape subsequent adaptive immunity. CD4+ T cells orchestrate B-cell activation and antibody class switching, while CD8+ T cells contribute to the elimination of infected hepatocytes during the pre-erythrocytic phase. Humoral responses target surface proteins on merozoites and infected reticulocytes, generating immunoglobulin G that can neutralise invasion and promote opsonisation. Memory B cells and long-lived plasma cells underpin durable antibody titres, yet the intermittent nature of antigen exposure—driven by low-density or asymptomatic parasitaemia and periodic relapses—often results in short-lived or focal immunity.

Antigenic diversity among blood-stage proteins such as merozoite surface proteins and reticulocyte-binding proteins complicates the acquisition of broad protection. In high-transmission settings, repeated exposure can gradually broaden specificity, whereas in low-transmission regions immunity may wane between episodes. Beyond antibodies, T helper 1 polarisation and regulatory T-cell subsets influence both parasite clearance and immunopathology. Understanding the interplay of cellular and humoral mechanisms is therefore key to vaccine design, serological surveillance and strategies to interrupt transmission.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Immunological Responses to Plasmodium vivax Malaria publication trend

The graph below shows the total number of articles in immunological responses to plasmodium vivax malaria across all publications each year (not limited to Nature Index journals).

Technical terms

Hypnozoite: Dormant liver-stage form of P. vivax that can reactivate to cause relapse.

Memory B cell: Long-lived lymphocyte capable of rapid antibody production upon re-exposure to antigen.

Serological exposure marker: Antigen or antibody used to indicate recent or past infection status in surveillance.

Reticulocyte-binding protein: Parasite ligand that mediates selective invasion of young red blood cells.

References

1. Plasmodium vivax serological exposure markers: PvMSP1-42-induced humoral and memory B-cell response generates long-lived antibodies. PLOS Pathogens (2024).
2. Naturally acquired antibody kinetics against Plasmodium vivax antigens in people from a low malaria transmission region in western Thailand. BMC Medicine (2022).
3. Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria. Frontiers in Cellular and Infection Microbiology (2023).